Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.
Yan Leyfman, MD
Advertisement
Articles by Yan Leyfman, MD
Explore the latest advancements in sarcoma immunotherapy, focusing on tumor microenvironment modulation and innovative treatment strategies for improved patient outcomes.
Authors of a manuscript published in ONCOLOGY® discuss how artificial intelligence may help with cancer detection and improving various patient outcomes.
Advances in next-generation sequencing and gene expression are reshaping T-cell lymphoma classification and the use of targeted therapies.
Artificial intelligence may mitigate overdiagnosis and unnecessary treatments in cancer care by integrating with precision medicine.
Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
Advertisement
Latest Updated Articles
Artificial Intelligence in Cancer Care: Addressing Challenges and Health EquityPublished: April 15th 2025 | Updated:
Highlighting Advancements in Personalized T-Cell Lymphoma TreatmentPublished: May 12th 2025 | Updated:
Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With CancerPublished: August 15th 2025 | Updated:
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment StrategiesPublished: March 7th 2025 | Updated:
Immune Modulation in Sarcoma: Targeting the Tumor MicroenvironmentPublished: July 28th 2025 | Updated:
Leveraging Artificial Intelligence to Bolster Equitable Cancer CarePublished: May 19th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
More Global Expertise and Talent Are Needed to Administer Cell Therapies
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
4
Region-Based Genetic Disorders Affect Cancer Treatment Decisions
5
